Actinium Pharmaceuticals Inc [ATNM] stock prices are up 0.99% to $9.20 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ATNM shares have gain 36.30% over the last week, with a monthly amount glided 36.50%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 11, March 2024, Actinium Pharmaceuticals Launches Actinium-225 Focused Strategic Initiative to Leverage Proprietary Cyclotron Based Manufacturing Technology to Address Growing Market Demand. In a post published today on Yahoo Finance, Actinium’s cyclotron produced Actinium-225 material has demonstrated radiochemical and radionuclidic purity identical to current gold-standard methods and has the potential to be significantly lower cost at commercial scale than currently available production methods.
From an analyst’s perspective:
Actinium Pharmaceuticals Inc [AMEX: ATNM] stock has seen the most recent analyst activity on September 06, 2023, when HSBC Securities initiated its Buy rating and assigned the stock a price target of $11.60. Previously, William Blair downgraded its rating to Mkt Perform on February 21, 2023. On September 08, 2022, Cantor Fitzgerald initiated with a Overweight rating and assigned a price target of $20 on the stock. B. Riley Securities started tracking the stock assigning a Buy rating and suggested a price target of $16 on August 25, 2022. Alliance Global Partners initiated its recommendation with a Buy and recommended $25 as its price target on November 05, 2020. B. Riley FBR Inc. started tracking with a Buy rating for this stock on December 06, 2017, and assigned it a price target of $2.75.
The stock price of Actinium Pharmaceuticals Inc [ATNM] has been fluctuating between $4.00 and $9.48 over the past year. Actinium Pharmaceuticals Inc [AMEX: ATNM] shares were valued at $9.20 at the most recent close of the market.
Analyzing the ATNM fundamentals
The Actinium Pharmaceuticals Inc [AMEX:ATNM] reported sales of 0.00M for trailing twelve months, representing a drop of -100.00%. Gross Profit Margin for this corporation currently stands at -5.6% with Operating Profit Margin at -463.75%, Pretax Profit Margin comes in at -439.83%, and Net Profit Margin reading is -429.39%. To continue investigating profitability, this company’s Return on Assets is posted at -0.55, Equity is -0.89 and Total Capital is -0.66. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.05.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.77 points at the first support level, and at 8.33 for the second support level. However, for the 1st resistance point, the stock is sitting at 9.75, and for the 2nd resistance point, it is at 10.29.
Actinium Pharmaceuticals Inc [ATNM] reported earnings per share of -$0.49 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.53/share, meaning a difference of $0.04 and a surprise factor of 7.50%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$0.58 per share as compared to estimates of -$0.48 per share, a difference of $-0.1 representing a surprise of -20.80%.
Ratios To Look Out For
It’s worth pointing out that Actinium Pharmaceuticals Inc [AMEX:ATNM]’s Current Ratio is 9.87. Also, the Quick Ratio is 9.87, while the Cash Ratio stands at 9.57.
